Dr Stefan Milde

Interests

Cell-based assay development and screening for drug discovery in dementia.

Research Focus

Keywords

dementia

neurodegeneration

drug discovery

screening

assay development

Clinical conditions

Alzheimer's disease

Huntington's disease

Parkinson's disease

Equipment

Cell culture

Enzyme assays

Fluorescence microscopy

High Content Imaging

Microscopy

Collaborators

No collaborators listed

Associated News Items


    Publications

    2013

    Milde S, Fox AN, Freeman MR, Coleman MP (2013), “Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.” Sci Rep 3:2567 Details

    Milde S, Gilley J, Coleman MP (2013), “Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.” Bioarchitecture 3(5):133-140 Details

    Milde S, Gilley J, Coleman MP (2013), “Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2.” PLoS Biol 11(4):e1001539 Details

    2012

    Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, MacDonald JM, Ziegenfuss JS, Milde S, Hou YJ, Nathan C, Ding A, Brown RH Jr, Conforti L, Coleman M, Tessier-Lavigne M, Züchner S, Freeman MR (2012), “dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.” Science 337(6093):481-4 Details

    2010

    Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW, Morton AJ (2010), “Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.” PLoS One 5(2):e9077 Details